Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK

• Asıl Yazarlar: Kristina S. Boye (Yazar), Dara Stein (Yazar), Louis S. Matza (Yazar), Jessica Jordan (Yazar), Ren Yu (Yazar), Kirsi Norrbacka (Yazar), Syed Wasi Hassan (Yazar), Luis-Emilio (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Adis, Springer Healthcare, 2019-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Introduction Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 rece...